Addition of AMPLATZER PFO Occluder to Medical Therapy is Beneficial in Patients with Cryptogenic Stroke and PFO

Article Information

DOI 
http://dx.doi.org/10.1177/155989771301005
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Emma Hitt Nichols, PhD
  1. Jeffrey L. Saver, MD
    1. University of California Los Angeles, Stroke Center, Los Angeles, California, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
Jul 2015111
Aug 2015200
Sep 2015100
Oct 2015333
Total1344

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Addition of AMPLATZER PFO Occluder to Medical Therapy is Beneficial in Patients with Cryptogenic Stroke and PFO
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cerebrovascular Disease Clinical Trials
Neurology
Cerebrovascular Disease
Neurology Clinical Trials